about
Malnutrition and wasting in renal diseaseConsensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics"Beta-hydroxy-beta-methylbutyrate supplementation in health and disease: a systematic review of randomized trialsTherapy of muscle wasting in cancer: what is the future?Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself.Cachexia: a new definition.Hypothalamic dopamine and serotonin in the regulation of food intake.Nutritional recommendations for the management of sarcopenia.Prevalence and clinical features of patients with the cardiorenal syndrome admitted to an internal medicine ward.Neurochemical mechanisms for cancer anorexia.β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia.Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting.Neural control of the anorexia-cachexia syndrome.The "parallel pathway": a novel nutritional and metabolic approach to cancer patients.l-carnitine and cancer cachexia: Clinical and experimental aspects.Parenteral nutrition in advanced cancer patients.Nutritional and metabolic support in patients with amyotrophic lateral sclerosis.Neuroinflammation: a contributing factor to the pathogenesis of cancer cachexia.Cancer cachexia: from molecular mechanisms to patient's care.Cachexia: a preventable comorbidity of cancer. A T.A.R.G.E.T. approach.Amino acids and hepatic encephalopathy.Iodine deficiency in pregnant women residing in an area with adequate iodine intake.Cardiac, Inflammatory and Metabolic Parameters: Hemodialysis versus Peritoneal Dialysis.The involvement of T regulatory lymphocytes in a cohort of lupus nephritis patients: a pilot study.Total and individual free fatty acid concentrations in liver cirrhosis.Chronic renal failure, cachexia, and ghrelin.Caloric restriction and L-carnitine administration improves insulin sensitivity in patients with impaired glucose metabolism.Sleep-inducing effect of beer: a melatonin- or alcohol-mediated effect?L-Carnitine induces recovery of liver lipid metabolism in cancer cachexia.Comparison of the performance of four different tools in diagnosing disease-associated anorexia and their relationship with nutritional, functional and clinical outcome measures in hospitalized patients.Stimulation of the nicotine antiinflammatory pathway improves food intake and body composition in tumor-bearing rats.Is spontaneous bacterial peritonitis an inducer of vasopressin analogue side-effects? A case report.Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca(2+)-dependent proteolytic systems in the muscle of tumour-bearing rats.Pathogenesis of cancer anorexia: still doubts after all these years?VMN/LHA functional inhibition in tumor-bearing rats suggests hypothalamic involvement in cancer anorexia.MuRF-1 and p-GSK3β expression in muscle atrophy of cirrhosis.Increased muscle proteasome activity correlates with disease severity in gastric cancer patients.Involvement of plasma leptin, insulin and free tryptophan in cytokine-induced anorexia.Ask-Upmark kidney and tubulointerstitial nephritis in a woman with severe renal failure.Effects of simvastatin administration in an experimental model of cancer cachexia.
P50
Q28246508-FAC1F9E6-E3F2-4D0A-BFD7-AC38020D8C64Q28269804-2D483DB4-4E21-4C58-A716-D4160BCB93CBQ28299062-00A50B0F-4FD8-47E6-A316-542C4C8B8953Q33979051-DA861FE9-DD65-4672-B2E2-6B931BC05761Q33991186-5473DB20-4477-4DD2-9707-465F1783AF69Q34013455-20F4D524-79C6-43C9-AB22-FF2DB51E84BDQ34071832-A360A0A6-5656-4106-965E-3F4D0CB18B20Q34125804-CFB3D30D-13D9-43FC-B86F-5EAC53760698Q34181036-72483B72-7DDB-451D-A8F9-B20F4E95703BQ34517552-F62791E8-62CE-43BE-BC64-394BA2A7B413Q34626024-F7E5F49A-A752-4F2E-82BF-8C32DAFD5168Q36893329-08FBD797-87B4-4525-ADB2-2516727743BEQ37247483-B61E19CE-1DBC-4739-A3F6-BB5DA9F49F82Q37769434-245282D9-9AE9-41B7-92AF-D26B2E694A7FQ37863019-E95784B0-D515-4C3C-A846-0637EF1CBDCCQ37988104-6E3D8290-B010-4A2D-B86C-F20C7F2EFCEAQ38017023-E198E154-F193-47CA-AF87-6DCEAEDB3D09Q38029385-991A8D8D-84A1-4306-B823-7823F7499983Q38029392-1C6B6F11-B291-466E-86C9-5C20480D9ED9Q38281984-167E4644-D5BF-47C5-83A1-1F3C0E60CCDAQ39462522-6D79D1E8-AD30-4962-8259-B93674D50F79Q39838658-1EC040CC-A4BE-4B11-B6DE-1DB41388158EQ41248193-B0874054-6F8A-44AB-860D-8A32C21941B8Q41346418-AD24E614-5E1C-488D-8150-5C237F16CE89Q41596933-350C4CA1-FAB5-41F4-B0C1-EC17A34859CFQ42030223-77F36ABB-31AB-434C-AFDA-A89E1BD4B152Q43064105-29B26380-7C21-47EA-B611-B58807764977Q43264127-2F9F12E8-BAB0-4F78-9D2E-6C080A21B21FQ43493969-6659A974-048B-472A-9841-D36A92659104Q43615290-E96D4813-4BE3-4916-B27C-B5EF7BDA173CQ43774540-515BBE6F-00F5-4C00-A45C-1C141F22DF9EQ43877225-C1B51904-A5AF-4B42-8624-5DA76827AD2CQ44117491-B0FD01FF-D2EE-4DEE-AF03-71736B2B2F76Q44266649-05DF0A70-9B59-4CC6-9734-2C9210769D28Q44267504-1BDF5516-4DED-4CCD-AF5B-D889FFC03E04Q44315702-6514331E-3178-4BDF-A7DB-0567ECA0DF2AQ44342943-95064585-E161-485A-AED8-757B86A28B9EQ44410433-9E8DDD98-B6EC-4805-A631-991354A1397DQ44413256-3E642B44-2F06-46EE-A7A1-33337C965407Q44660585-C4DE4449-B8BA-4CC6-B4DE-818D21CB7DE9
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Filippo Rossi Fanelli
@ast
Filippo Rossi Fanelli
@en
Filippo Rossi Fanelli
@es
Filippo Rossi Fanelli
@nl
Filippo Rossi Fanelli
@sl
type
label
Filippo Rossi Fanelli
@ast
Filippo Rossi Fanelli
@en
Filippo Rossi Fanelli
@es
Filippo Rossi Fanelli
@nl
Filippo Rossi Fanelli
@sl
prefLabel
Filippo Rossi Fanelli
@ast
Filippo Rossi Fanelli
@en
Filippo Rossi Fanelli
@es
Filippo Rossi Fanelli
@nl
Filippo Rossi Fanelli
@sl
P1053
E-9587-2011
P106
P1153
7003772374
P21
P31
P3829
P496
0000-0002-8674-1672